Search Results - Febe Smits
- Showing 1 - 3 results of 3
-
1
Immune signatures in older patients with newly diagnosed multiple myeloma are associated with survival outcomes of first‐line therapy irrespective of frailty levels by Wassilis S. C. Bruins, Febe Smits, Carolien Duetz, Kazem Nasserinejad, Kazimierz Groen, Charlotte L. B. M. Korst, A. Vera de Jonge, Rosa Rentenaar, Tamara Hageman, Meliha Cosovic, Merve Eken, Inoka Twickler, Paola M. Homan‐Weert, Christie P. M. Verkleij, Kristine Frerichs, Mark‐David Levin, Ellen van der Spek, Inger S. Nijhof, Roel van Kampen, Niels W. C. J. van de Donk, Sonja Zweegman, Tuna Mutis
Published 2025Get full text
Artículo Open Access -
2
Uncovering the ultra‐frail: A distinct subgroup in non‐transplant eligible newly diagnosed patients with multiple myeloma, with an inferior clinical outcome by Kazimierz Groen, Febe Smits, Kazem Nasserinejad, Mark‐David Levin, Josien C. Regelink, Gert‐Jan Timmers, Esther G. M. de Waal, Matthijs Westerman, Gerjo A. Velders, Koen de Heer, Rineke B. L. Leys, Roel J. W. van Kampen, Claudia A. M. Stege, Maarten R. Seefat, Inger S. Nijhof, Ellen van der Spek, Saskia K. Klein, Niels W. C. J. van de Donk, Paula F. Ypma, Sonja Zweegman
Published 2025Get full text
Artículo Open Access -
3
Assessing frailty in myeloma: The pursuit of simplicity may sacrifice precision of predicting clinical outcomes by Kazimierz Groen, Febe Smits, Kazem Nasserinejad, Mark‐David Levin, Josien C. Regelink, Gert‐Jan Timmers, Esther G. M. de Waal, Matthijs Westerman, Gerjo A. Velders, Koen de Heer, Rineke B. L. Leys, Roel J. W. van Kampen, Claudia A. M. Stege, Maarten R. Seefat, Inger S. Nijhof, Ellen van der Spek, Saskia K. Klein, Niels W. C. J. van de Donk, Paula F. Ypma, Sonja Zweegman
Published 2024Get full text
Artículo Open Access